Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bioventus Inc. Director's Dealing 2021

Feb 12, 2021

32934_dirs_2021-02-11_56bb1109-93b1-4dbc-bff1-6b78e038f8a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: STALNECKER SUSAN M (Director)